Gardner Lewis Asset Management’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History

Gardner Lewis Asset Management’s Portfolio AVEO Stock Details AVEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-146,032	Closed	-$2.18M	–	96
2022 Q4	$2.18M	Buy	+146,032	New	+$2.02M	0.75%	37

Gardner Lewis Asset Management's AVEO Position: Q1 2023 in Review

Gardner Lewis Asset Management sold out of AVEO Pharmaceuticals, Inc. (AVEO) in Q1 2023, closing a stake of 146,032 shares — an estimated $2.18M sold.

Gardner Lewis Asset Management first reported a position in AVEO in Q4 2022 and held it in 1 quarter. The position peaked at $2.18M in Q4 2022. 0 funds tracked by Wall St. Rank hold AVEO as of Q1 2023.

Gardner Lewis Asset Management reported no remaining AVEO Pharmaceuticals, Inc. position as of Q1 2023 after selling out during the quarter.
Gardner Lewis Asset Management sold 146,032 AVEO Pharmaceuticals, Inc. shares in Q1 2023, an estimated $2.18M.
Gardner Lewis Asset Management first reported a position in AVEO Pharmaceuticals, Inc. in Q4 2022 and held it in 1 quarter.
Gardner Lewis Asset Management's AVEO Pharmaceuticals, Inc. position peaked at $2.18M in Q4 2022.
0 funds tracked by Wall St. Rank held AVEO Pharmaceuticals, Inc. as of Q1 2023.

Based on Gardner Lewis Asset Management's 13F filing for Q1 2023, filed 12 May 2023.